The Indian insurance industry has a problem that nobody in the industry wants to talk about: most of its bestselling products are neither good insurance nor good investments. They are a compromise between the two — and compromises in finance tend to serve the product seller more than the buyer.
Let's examine exactly what's happening.
The three products to understand
Endowment policies combine a death benefit with a savings component. You pay a premium for 15–20 years and receive a "maturity benefit" at the end. They feel responsible and disciplined. The problem: the insurance cover is typically 10–15x the annual premium — far below what most families actually need. And the "investment" portion earns 4–5% per annum, roughly matching inflation and well below what even a conservative debt mutual fund delivers.
Money-back policies return a portion of the sum assured at regular intervals. This sounds attractive — you get money back while staying insured. The reality: those periodic payouts come directly from your premium, reducing the corpus that could have been compounding. The effective return is typically 3–4%.
ULIPs (Unit Linked Insurance Plans) invest your premium in market-linked funds while providing a life cover. The pitch is compelling: market returns plus insurance in one product. The reality: high charges (premium allocation, fund management, mortality, policy administration) in the early years destroy compounding potential. A ULIP's effective return over 10 years frequently underperforms a simple mutual fund + term insurance combination by 2–3% per annum — which, compounded, is a significant sum.
The numbers that reveal the trap
Consider a 35-year-old male buying a traditional endowment policy:
| Endowment Policy | Term + Mutual Fund | |
|---|---|---|
| Annual premium | ₹1,00,000 | ₹1,00,000 |
| Term insurance cost (₹1 crore cover) | Included (but cover is only ₹10–12L) | ₹12,000/year |
| Amount actually invested | ~₹40,000–50,000 (net of charges) | ₹88,000 into mutual fund SIP |
| Life cover provided | ₹10–12 lakh | ₹1 crore |
| Corpus after 20 years (approx) | ₹28–32 lakh (at 4–5% return) | ₹80–90 lakh (at 10% CAGR) |
Same ₹1 lakh annual outflow. One gives you ₹10 lakh of cover and ₹30 lakh at maturity. The other gives you ₹1 crore of cover and ₹85 lakh at maturity. This is not a close call.
Why are these products so popular then?
Because they are sold aggressively, and they sell well for understandable reasons:
- They feel safe. A "guaranteed" maturity amount feels more secure than market-linked returns. The guarantee is real — but the return on that guarantee is so low that it barely compensates for inflation.
- They bundle two needs into one product. Most people don't want to think about insurance and investing separately. One premium, one policy, one agent — it feels simpler. This simplicity has a very high price.
- The commission structure rewards the agent, not the buyer. Traditional endowment products pay agents 25–40% of the first-year premium as commission, tapering in subsequent years. The agent's incentive is to sell you the most expensive, longest-tenure policy possible.
- Tax benefits create an illusion of returns. Section 80C deductions on premiums feel like a bonus. But the same 80C deduction is available on ELSS mutual funds with far superior returns — so this argument doesn't hold up.
The right way to think about insurance
Insurance has one job: to replace your income if you die prematurely, so that your dependants can maintain their standard of living. That's it. Insurance is not meant to generate returns. When you mix that job with an investment objective, both suffer.
The cleanest framework in financial planning is this: separate protection from wealth-building entirely.
- Buy pure term insurance for protection. A ₹1–2 crore term cover for a 35-year-old costs ₹10,000–15,000 per year. It pays your family the full cover if you die during the policy term. It pays nothing if you survive — and that's exactly the point. You're not buying a savings plan. You're buying peace of mind that your family is protected.
- Invest the rest in mutual funds, NPS, or other instruments appropriate for your goals and timeline. These will outperform the investment component of any bundled policy.
What to do if you already hold these policies
This is where it gets nuanced — and where a blanket "surrender everything" recommendation can be wrong.
Policies in early years (under 5 years): Surrender value is very low and surrender charges are high. Evaluate the long-term cost vs the cost of surrendering now. Often still worth surrendering and redirecting premiums.
Policies in middle years (5–15 years): Calculate the effective yield on remaining premiums to maturity. If the effective return is under 5%, surrendering and reinvesting in mutual funds typically wins over a 10-year horizon.
Policies near maturity (under 5 years to go): In most cases, continuing to maturity makes sense. The damage has been done; the switching cost outweighs the benefit.
Every case is different. The right answer depends on your policy terms, surrender value, remaining tenure, and tax position. This is exactly the kind of analysis we do in a free consultation — with no incentive to recommend any particular outcome.
The takeaway
The insurance trap isn't a scam. It's a product design that prioritises simplicity and agent economics over client outcomes. Most families in Tamil Nadu have at least one endowment, money-back, or ULIP policy running — often multiple. Most of them are quietly underperforming what a term + mutual fund combination would have delivered.
The solution isn't complicated. Buy cheap, high-cover term insurance. Invest separately in mutual funds aligned to your goals. Review both annually. That structure will outperform any bundled product over any meaningful time horizon — and leave your family far better protected.